Bandyopadhyay Arkapal, Palepu Sarika, Bandyopadhyay Krishna, Handu Shailendra
Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh.
Department of Community Medicine, VCSGGMS and RI, Srinagar.
Monaldi Arch Chest Dis. 2020 Sep 4;90(3). doi: 10.4081/monaldi.2020.1437.
COVID-19 has been affecting mankind round the globe. The incidence of this infectious disease of respiratory origin is constantly on rise. Another infectious disease widely prevalent is tuberculosis (TB). During past corona virus pandemics of Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome, coinfection with TB was seen. We present this review as the co-infection of COVID-19 with TB has not been assessed yet, imposing a greater global threat. We suggest few measures to be implemented without delay for effectively screening the suspects of co-infection and also follow up of non-suspect patients in the post-pandemic phase.
新冠病毒病(COVID-19)一直在全球范围内影响着人类。这种呼吸道起源的传染病发病率持续上升。另一种广泛流行的传染病是结核病(TB)。在过去严重急性呼吸综合征和中东呼吸综合征冠状病毒大流行期间,曾发现与结核病的合并感染。由于尚未评估COVID-19与结核病的合并感染情况,这对全球构成了更大威胁,因此我们撰写了本综述。我们建议立即采取一些措施,以有效筛查合并感染疑似病例,并在大流行后阶段对非疑似患者进行随访。